Model
Edge
Seres Therapeutics
0001808592
Filing Type
4
Filing Date
11/18/2024
Updated
11/19/24, 2:20 PM
Copy Ref
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership